References
- Bygdeman M. Clinical use of prostaglandins for pregnancy termination. Pop Rep series G 1976; 7
- Lange A P., Secher N J. Midtrimester and missed abortion treated with intramuscular 15(S)-15-methyl PGF2α. Prostaglandins 1977; 14: 502–504
- Laursen N H., Cederqvist L L., Wilson K H. Management of intrauterine fetal death with prostaglandin E2 vaginal suppositories. Am J Obstet Gynecol 1980; 137: 753–757
- Laursen N H., Den T, Scher J, Iliescu C, Wilson K H. A new abortion technique: Intravaginal and intramuscular prostaglandin. Obstet Gynecol 1981; 58: 96–100
- Pedersen P H., Larsen J F., Sørensen B. Induction of labor with prostaglandin F2α in missed abortion, foetus mortuus and anencephalia. Prostaglandins 1972; 2: 135
- Scher J, Jen D-Y, Moshipur J, Kerenyl T D. A comparison between vaginal prostaglandin E2 suppositories and intrauterine extra-amniotic prostaglandins in the management of fetal death in utero. Am J Obstet Gynecol 1980; 137: 769–772
- Wallenburg H CS, Keirse M JNC, Freie H MP, Blac-Quire J F. Intramuscular administration of 15(S)-15-methyl-prostaglandin F2α for induction of labour in patients with fetal death. 1980; 87: 203–209
- Ylikorkala O, Kirkinen P, Järvinen P A. Intramuscular administration of 15-methyl-prostaglandin F2α for induction of labour in patients with intrauterine fetal death or an anencephalic fetus. Br Obstet Gynaecol 1976; 83: 502–504